These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12037452)

  • 21. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.
    Parmar NV; Kanwar AJ; Minz RW; Parsad D; Vinay K; Tsuruta D; Ishii N; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2013; 79(1):70-6. PubMed ID: 23254732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide.
    Pandya AG; Sontheimer RD
    Arch Dermatol; 1992 Dec; 128(12):1626-30. PubMed ID: 1456758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
    Almugairen N; Hospital V; Bedane C; Duvert-Lehembre S; Picard D; Tronquoy AF; Houivet E; D'incan M; Joly P
    J Am Acad Dermatol; 2013 Oct; 69(4):583-8. PubMed ID: 23850258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris.
    Sharma VK; Khandpur S
    Clin Exp Dermatol; 2013 Aug; 38(6):659-64. PubMed ID: 23837939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemphigus in North-Western Yemen: A therapeutic study of 75 cases.
    Khatri ML
    Indian J Dermatol Venereol Leprol; 2016; 82(3):359. PubMed ID: 27088959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
    Becker LR; Bastian BC; Wesselmann U; Karl S; Hamm H; Bröcker EB
    Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulse intravenous cyclophosphamide therapy in pemphigus.
    Fleischli ME; Valek RH; Pandya AG
    Arch Dermatol; 1999 Jan; 135(1):57-61. PubMed ID: 9923782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
    Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
    Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study.
    Bhat R; Sharma VK; Ramam M; Kumar A
    Dermatol Online J; 2005 Dec; 11(3):4. PubMed ID: 16409900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged remission of pemphigus induced by dexamethasone-cyclophosphamide pulse therapy.
    Gupta R
    Indian J Dermatol Venereol Leprol; 2007; 73(2):121-2. PubMed ID: 17456923
    [No Abstract]   [Full Text] [Related]  

  • 35. A review of pulse therapy in 74 patients with pemphigus.
    Roga G; Augustine M
    Indian J Dermatol Venereol Leprol; 2018; 84(3):331-333. PubMed ID: 29600798
    [No Abstract]   [Full Text] [Related]  

  • 36. Pulse therapy in pemphigus: report of 11 cases.
    Fernandes NC; Menezes M
    An Bras Dermatol; 2013; 88(4):672-5. PubMed ID: 24068153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study.
    Fontenelle LF; Bueno-Filho R; Vernal S; Delfino R; Barbosa GSL; Donadi EA; Roselino AM
    An Bras Dermatol; 2023; 98(6):774-780. PubMed ID: 37355353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone-cyclophosphamide pulse therapy in systemic lupus erythematosus.
    Dhabhai R; Kalla G; Singhi MK; Ghiya BC; Kachhawa D
    Indian J Dermatol Venereol Leprol; 2005; 71(1):9-13. PubMed ID: 16394353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.
    Hayag MV; Cohen JA; Kerdel FA
    J Am Acad Dermatol; 2000 Dec; 43(6):1065-9. PubMed ID: 11100024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.